FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Last Updated: Feb 3, 2025

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Read more.